Anavex Life Sciences Corp. Shares Close the Week 26.3% Higher - Weekly Wrap
The company saw its shares close the week 26.3% higher than last week, with trading volume lower than its 30 day average.
Mar 12, 2021 by Kwhen Finance Editors
- Shares traded as high as $15.17 and as low as $11.92 this week.
- Trading volume this week was 22.7% higher than the 10-day average and 9.9% lower than the 30-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.0.
- The Relative Strength Index (RSI) on the stock was above 70, indicating it may be overbought.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed below its Bollinger band, indicating it may be oversold.
Market Comparative Performance
- The company's share price beats the S&P 500 Index this week, beats it on a 1-year basis, and beats it on a 5-year basis
- The company's share price beats the Dow Jones Industrial Average this week, beats it on a 1-year basis, and beats it on a 5-year basis
- The company share price beats the performance of its peers in the Health Care industry sector this week, beats it on a 1-year basis, and beats it on a 5 year basis
|Name||DoD %Δ||YTD %Δ||1 Yr %||52-Week H %||52-Week L %|
|Anavex Life Sciences Corp.||4.1||174.4||459.2|
|Dow Jones Industrial Average||0.5||8.2||45.2||-0.3||84.0|
|S&P 500 Index||0.6||6.0||49.9||-0.6||83.0|
Peer Group Comparative Performance
- The company's stock price performance year-to-date beats the peer average by 452.9%
- The company's stock price performance over the past 12 months beats the peer average by 172.1%
|Name||MKT CAP (USD)||P/E||YTD %Δ||1 Yr %Δ||52-Week H %||52-Week L %|
|Anavex Life Sciences Corp.||AVXL||0||174.4||459.2|
|Corcept Therapeutics Incorporated.||CORT||28.5||-1.4||138.8|
|Ligand Pharmaceuticals Incorporated||LGND||-879.4||64.1||100.5|
|BioCryst Pharmaceuticals Inc.||BCRX||-12.3||69.7||471.9||-7.2||717.7|
|Palatin Technologies Inc.||PTN||-6.9||17.9||73.2||-38.4||125.5|
|ARCA biopharma Inc.||ABIO||0||7.5||59.6|
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to firstname.lastname@example.org. © 2021 Kwhen Inc.
Was this content valuable for you?